A recent study by researchers at the Garvan Institute of Medical Research has uncovered a critical link between gene variants associated with leukemia and the development of autoimmune diseases.
The study reveals how these genetic changes can lead to the production of “rogue” immune cells, particularly killer T cells, which are normally responsible for destroying harmful cells and pathogens.
These rogue cells, however, can mistakenly attack the body’s own cells, driving autoimmune diseases.
The connection between leukemia and autoimmune diseases has puzzled scientists for some time. It has been observed that patients with leukemia often develop autoimmune conditions such as rheumatoid arthritis or aplastic anemia.
This new research sheds light on the underlying mechanisms that link these conditions, highlighting the role of killer T cells in both leukemia and autoimmune disorders.
Killer T cells are a vital part of the immune system, designed to seek out and destroy cells that pose a threat, such as cancer cells or infectious agents. However, the study found that certain gene variations affecting a protein called STAT3 can cause these T cells to become “rogue.”
When this protein, which is crucial for controlling the growth and function of immune cells, is altered, it can lead to unchecked growth of these T cells.
The result is that these cells become abnormally large and aggressive, bypassing the usual immune checkpoints that prevent them from attacking the body’s own tissues.
This process is a double-edged sword: while cancers can thrive when the immune system fails to recognize and destroy tumor cells, autoimmune diseases occur when the immune system mistakenly targets healthy cells.
The study showed that even a small percentage—just 1-2%—of T cells going rogue could be enough to trigger an autoimmune response.
To uncover these findings, the researchers used advanced high-resolution screening techniques to examine blood samples from children with rare inherited autoimmune diseases.
They employed CRISPR/Cas9, a powerful genome editing tool, to investigate the effects of genetically altering the STAT3 protein in mouse models.
STAT3 is a protein found throughout the body and is integral to a range of cellular functions, including the regulation of both B cells and T cells, which are crucial components of the immune system.
The study’s findings have significant implications for the treatment of autoimmune diseases. By identifying the specific genetic mutations that lead to the growth of rogue T cells, doctors could potentially target medications more effectively.
For example, JAK inhibitors, which are already approved by the Therapeutic Goods Administration (TGA), could be used more precisely based on the presence of these mutations.
Furthermore, the research identified two receptor systems involved in cellular communication that are linked to stress responses. Understanding these systems could lead to the development of new screening technologies.
These could allow clinicians to sequence the complete genome of every cell in a blood sample, identifying which cells have the potential to turn rogue and cause disease.
This study, led by Dr. Etienne Masle-Farquhar and published in the journal Immunity, provides a new perspective on the relationship between cancer and autoimmune diseases.
It opens up possibilities for more targeted therapies and preventive strategies, potentially improving outcomes for patients at risk of both leukemia and autoimmune conditions.
As researchers continue to explore the genetic underpinnings of these diseases, we may move closer to more effective treatments and a better understanding of how to prevent rogue immune cells from wreaking havoc on the body.
If you care about cancer, please read studies about supplement that may increase cancer risk, and can vitamin D help prevent or treat cancer?
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing berry that can prevent cancer, diabetes, and obesity.
Copyright © 2024 Knowridge Science Report. All rights reserved.
